ID
29055
Description
Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Keywords
Versions (5)
- 10/5/17 10/5/17 -
- 2/22/18 2/22/18 -
- 2/22/18 2/22/18 -
- 2/22/18 2/22/18 -
- 9/17/21 9/17/21 -
Copyright Holder
gsk
Uploaded on
February 22, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Ropinirole Case Report Form GSK RRL100013
Vital signs descirptions
Similar models
Vital signs descirptions
C0035258 (UMLS CUI [1,2])
C1442085 (UMLS CUI [1,2])